Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.

Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.

http://www.wikidata.org/entity/Q35397206

about

The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer Intestinal microbiota transplant - current state of knowledge Regulation of immune cell function by short-chain fatty acids Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals Chemically defined diet alters the protective properties of fructo-oligosaccharides and isomalto-oligosaccharides in HLA-B27 transgenic rats Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 Human gut microbiota and healthy aging: Recent developments and future prospective Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health.Dietary intake of soluble fiber and risk of islet autoimmunity by 5 y of age: results from the TEDDY study.Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity.Caecal pH is a biomarker of excessive colonic fermentation.No association of dietary fiber intake with inflammation or arterial stiffness in youth with type 1 diabetes.pH-Mediated Microbial and Metabolic Interactions in Fecal Enrichment Cultures.Epithelial cell-specific MyD88 signaling mediates ischemia/reperfusion-induced intestinal injury independent of microbial status.Diet Hypotheses in Light of the Microbiota Revolution: New Perspectives.16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects.Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.The function of our microbiota: who is out there and what do they do?The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon.Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.Alteration of intestinal microbiota in mice orally administered with salmon cartilage proteoglycan, a prophylactic agent.High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects.Modulation of immune homeostasis by commensal bacteria.Colorectal Oncogenesis and Inflammation in a Rat Model Based on Chronic Inflammation due to Cycling DSS Treatments.Mucosal Immune Development in Early Life: Setting the Stage.The Differential Proteome of the Probiotic Lactobacillus acidophilus NCFM Grown on the Potential Prebiotic Cellobiose Shows Upregulation of Two β -Glycoside Hydrolases Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands Prebiotics, Fermentable Dietary Fiber, and Health Claims.The gut microbiome of healthy Japanese and its microbial and functional uniqueness.Effects of Early Intervention with Sodium Butyrate on Gut Microbiota and the Expression of Inflammatory Cytokines in Neonatal Piglets.Effects of Liver Resection on Hepatic Short-Chain Fatty Acid Metabolism in Humans Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease.Probiotic therapy as a novel approach for allergic disease.Quantification of in Vivo Colonic Short Chain Fatty Acid Production from Inulin.Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.The effects of commensal bacteria on innate immune responses in the female genital tract.

P2860

Q24306831-23064C62-3F8D-4FC8-ADFD-5178B980C16D Q26741017-80FBD336-EABA-4568-801A-C75C29FE0C80 Q26748416-FB79F54C-9661-414F-B967-3779FBA25B92 Q26829933-6FB465D4-4255-444C-8140-BE9A43EE05BE Q27332418-48B6C223-51F7-4EF0-A57C-DAA7AE6F33FE Q28081831-AB027100-181E-45D6-8882-94049D9399F5 Q28509150-FEDCE9B8-CD21-4C17-8D08-2DC1D3CBCE97 Q28586306-ADBF5FC4-FEB7-401D-9B4A-13AEB8114784 Q28710518-5D614335-9B5B-4A06-8EC6-7C9EBEFE547A Q30248903-980FBD74-CD51-4192-938B-5C0679EE53D9 Q30357281-D1890896-C0E1-4124-A221-DFC21EF89283 Q31123584-D7CA009F-F970-44C9-A0F3-5272BFB5D120 Q33346196-49EB6F17-7A1A-441C-9E2D-C46BDF744995 Q33564151-4E4D0064-9E40-4959-A457-B13E72441BBC Q33570748-D23F6419-29FD-463E-8105-0FE3C5C1DA01 Q33634286-2B4E2AF4-54D9-4200-A96E-D59F52A5730A Q33689251-07F4F3AA-3E9C-4425-A96F-D7A6460858A4 Q33851769-948E5A5C-FE38-4B0D-A276-010FAE80A8A2 Q33879834-EB8D81F1-D78B-4576-8493-0302302EE300 Q33920905-B82F1A3F-29E1-40C2-A421-50B672AA1518 Q34120699-E754358C-0288-4BAC-802F-1954980007E2 Q34392557-60F9E70B-DA94-459A-9EF6-7161D0FDABC7 Q34452017-6F7BCD57-3C7D-417C-A94C-46884132BC0E Q34900690-661EB5D4-4F24-4C56-B9AB-8950140DD703 Q34990474-19583C23-7DEF-44C2-B1EB-1A1F29AA18E7 Q35043961-B13A4A72-1040-43C8-BC04-8D95CA1D006F Q35069784-1EF20EBD-B978-45A0-A551-B23842916EF8 Q35295244-876F0E31-879E-4820-A1A9-692D4550124E Q35558518-258417A4-F469-4C63-8CF4-E4654329E5FF Q35563433-0C52BC6D-AD3D-4260-91F8-B6BE75168CA9 Q35784465-65400633-37EF-462D-B1F1-736C13AA9534 Q35895688-04501FCE-0B0F-40CE-8800-50FEFE74495D Q35948206-9BA66CC1-94E0-42D4-9A9F-0A9360A044B6 Q36128519-18CF750E-A50D-4679-A59E-694FB33D0E0E Q36189874-9D186E23-FE07-4B9E-AA7B-39467D5055B2 Q36241633-3A50ABEE-F9E3-415D-B8C6-F018F4EF08F8 Q36250265-0F92F01E-519A-449D-A481-D7649D378B4A Q36329760-0F96F64D-4551-4495-835C-778D3793A452 Q36453623-8461029D-1958-482B-90FD-421A5915C649 Q36634992-EF7DC57A-4879-46B7-ACE4-37C3FC096FEB

P2860

Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.

http://www.wikidata.org/entity/Q35397206

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Anti-inflammatory properties o ...... to inflammatory bowel disease.

@ast

Anti-inflammatory properties o ...... to inflammatory bowel disease.

@en

type

label

Anti-inflammatory properties o ...... to inflammatory bowel disease.

@ast

Anti-inflammatory properties o ...... to inflammatory bowel disease.

@en

prefLabel

Anti-inflammatory properties o ...... to inflammatory bowel disease.

@ast

Anti-inflammatory properties o ...... to inflammatory bowel disease.

@en

P1433

Q35397206-20D77962-38FD-4A81-AD5C-5E2B2D55EEF8

P1476

Q35397206-2BB6685D-91B2-4955-B6DC-0A5228D4F004

P2093

Q35397206-362C0062-FCA3-48D4-936F-2FF5B6916ACF

Q35397206-89506B07-C29A-49E3-AC89-403311C6C0A3

Q35397206-9B5223F3-0F01-4C25-8534-4E402E65A796

Q35397206-9F8DA58A-95FA-4C09-B8EA-0CCC014805D6

P2860

Q35397206-07223442-136C-4E21-B222-E5C19BE820A2

Q35397206-0EA5E4B1-0403-46AF-9B3F-D0D3E2D4CE7B

Q35397206-161010B6-AF26-4C89-B86E-5233DB925BDF

Q35397206-1EF49E0F-AD14-4EA4-BDAD-609145FDFF32

Q35397206-28F4C6E7-9E71-4C68-AF73-0F46D8CB7A1C

Q35397206-2B57B4E4-8A6C-4682-AA52-5C1D20B78C78

Q35397206-509A2759-5B17-480A-B94E-F7807FF17241

Q35397206-69722ACE-16A9-4733-88C3-BDAF48C1D29E

Q35397206-752E3820-8242-4F36-8611-D3A7FBAA059E

Q35397206-79DDCA47-0494-443C-87F2-B4B4A91E1208

P304

Q35397206-0A1E3BFC-E700-48F9-AAB0-79B3548DC307

P31

Q35397206-F38B3EE8-8891-4AF7-B952-BDE2A424F22B

P356

Q35397206-E7E016AF-9213-4DD6-81EA-870AE888E1B1

P407

Q35397206-B1865CCB-E97F-4CE4-B628-B4FCECA3AF6C

P433

Q35397206-0F0501D8-5A4B-4328-BEE2-E4AC20058BE4

P478

Q35397206-957BE515-CC18-4EC3-8066-1E06882D01AA

P577

Q35397206-5BA0FF93-6E59-461F-859C-23CCDC560D4C

P698

Q35397206-CF55AD22-9BE2-4BEE-BE72-716064C8D55F

P921

Q35397206-1FCB9613-AB58-440E-83F7-DD4737F43696

Q35397206-BD9181F1-124B-4832-8082-B27FCA94B2FD

P932

Q35397206-DCD82AEA-78D8-415B-B33E-4E673A913480

P356

WJG.V13.I20.2826

P1433

World Journal of Gastroenterology

P1476

Anti-inflammatory properties o ...... to inflammatory bowel disease

@en

P2093

Alexander Vidal

http://www.w3.org/2001/XMLSchema#string

Fredrik Westberg

http://www.w3.org/2001/XMLSchema#string

Martin Kjerrulf

http://www.w3.org/2001/XMLSchema#string

Sofia Tedelind

http://www.w3.org/2001/XMLSchema#string

P2860

The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids

Ethanol prevents development of destructive arthritis

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids

Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation

Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial

Colonic health: fermentation and short chain fatty acids.

Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides.

Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis.

Role of intestinal bacteria in nutrient metabolism.

P304

2826-2832

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I20.2826

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17569118

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

4395634

http://www.w3.org/2001/XMLSchema#string